Abstract
One of the side-effects accompanying low-dose recombinant interleukin-2 (rIL-2)-based immunotherapy is salivary hypofunction. We evaluated the functional and compositional whole salivary profile at both resting and stimulated conditions in 10 renal cell carcinoma patients who received prolonged low-dose rIL-2-based immunotherapy. Following the termination of 4 weeks of the combined administration of rIL-2 and recombinant interferon-alpha (rIFN-alpha), we found significant reductions of salivary flow rates at resting condition, accompanied by significant multiple compositional alterations, including increases in calcium, magnesium and phosphate concentrations, and significant reductions in total protein concentration. In contrast, no flow rate reduction was noted under stimulated condition, and the only significant altered compositional component was the phosphate. We recommend salivary-supporting therapies and anticariogenic treatments for patients undergoing low-dose rIL-2-based immunotherapy.
References
May 1, 1992·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Y MarmaryJ Katz
Sep 1, 1992·Journal of Surgical Oncology·H KonnoT Tadakuma
Aug 1, 1989·The Journal of the American Dental Association·I D Mandel
Dec 1, 1987·The Journal of Pathology·N I Walker, G C Gobé
Apr 1, 1985·The Journal of the American Dental Association·P C FoxB J Baum
Sep 1, 1965·Immunochemistry·G ManciniJ F Heremans
Jan 1, 1996·The Journal of Urology·E Lopez HänninenJ Atzpodien
Nov 1, 1995·Journal of Cellular Physiology·J KatzJ Shemer
Nov 1, 1995·Journal of the American Academy of Dermatology·A A GaspariJ M Rowe
Apr 1, 1995·British Journal of Rheumatology·D BoumbaH M Moutsopoulos
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FyfeA C Louie
Jun 1, 1993·International Immunology·C S Via, F D Finkelman
Apr 22, 1994·Science·A J RamsayM Kopf
May 15, 1994·Experientia·M A Devi, N P Das
Jan 1, 1993·Journal of Diabetes and Its Complications·H Ben-AryehD Laufer
Jul 1, 1996·The Journal of Urology·G HofmockelH G Frohmüller
Aug 1, 1996·Arthritis and Rheumatism·Y OhyamaK Nomoto
Oct 1, 1996·Archives of Otolaryngology--head & Neck Surgery·R M NaglerA Nagler
Jun 1, 1996·Biological Psychiatry·H Ben-AryehD Laufer
Jun 1, 1997·Bone Marrow Transplantation·D NachbaurD Niederwieser
Oct 23, 1997·Bone Marrow Transplantation·A NaglerY Marmary
Feb 17, 1998·Head & Neck·R M NaglerA Nagler
Jun 18, 1999·Bone Marrow Transplantation·R M Nagler, A Nagler
Citations
Jun 12, 2009·PloS One·Kai GaoDavid T Wong
Mar 20, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S B JensenUNKNOWN Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cance
Sep 7, 2004·Head & Neck·Mark S ChambersJack W Martin
Sep 4, 2009·European Journal of Cancer Care·A DaviesS Mercadante
Sep 17, 2003·Oral Diseases·C Scully